Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Monday, November 11th. Analysts expect Crescent Capital BDC to post earnings of $0.57 per share for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. The company had revenue of $48.95 million for the quarter, compared to analysts' expectations of $48.05 million. During the same period last year, the firm posted $0.56 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Crescent Capital BDC Stock Performance
NASDAQ:CCAP traded down $0.47 during mid-day trading on Monday, reaching $17.55. The company's stock had a trading volume of 211,793 shares, compared to its average volume of 132,189. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17. The stock has a market cap of $650.40 million, a P/E ratio of 6.38 and a beta of 0.81. The firm's fifty day moving average price is $18.41 and its two-hundred day moving average price is $18.36. Crescent Capital BDC has a 12-month low of $15.91 and a 12-month high of $19.63.
Crescent Capital BDC Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Monday, September 30th were issued a $0.42 dividend. The ex-dividend date was Monday, September 30th. This represents a $1.68 annualized dividend and a yield of 9.57%. This is a boost from Crescent Capital BDC's previous quarterly dividend of $0.09. Crescent Capital BDC's dividend payout ratio (DPR) is currently 61.09%.
Analyst Upgrades and Downgrades
CCAP has been the topic of several research analyst reports. Bank of America lowered their price target on Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating on the stock in a report on Thursday, August 15th. LADENBURG THALM/SH SH initiated coverage on Crescent Capital BDC in a report on Monday, September 30th. They issued a "buy" rating and a $20.00 target price on the stock. Finally, Wells Fargo & Company cut their price target on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 14th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.00.
Read Our Latest Stock Analysis on Crescent Capital BDC
Crescent Capital BDC Company Profile
(
Get Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Recommended Stories
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.